Stocks
Denali Therapeutics (DNLI) EV/EBITDA US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| EV/EBITDA | ? | -16.1 | 3.86 | 5.46 | -5.21 | -4.16 | -5.03 | |
| Changes by years, y/y, % | -115% | -124% | +41% | -195% | -20% | |||
Denali Therapeutics. EV/EBITDA
Denali Therapeutics. EV/EBITDA, changes, %
Denali Therapeutics (DNLI) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -3.09 | -2.96 | -3.18 | -3.90 | -5.03 | -5.03 | |
| Changes by years, y/y, % | -169% | -270% | -62% | -28% | +63% | |||
| Changes by quarters, q/q, % | -43% | -4% | +7% | +22% | +29% | |||
